Dianthus Therapeutics (DNTH) Non Operating Income (2022 - 2025)

Dianthus Therapeutics' Non Operating Income history runs 4 years deep, the most recent figure standing at -$360000.0 for Q3 2025.

• In Q3 2025, Non Operating Income fell 107.62% year-over-year to -$360000.0; the TTM figure through Sep 2025 stood at $10.1 million (down 9.46% YoY), while the FY2024 annual figure was $16.9 million, up 28258.33% from the prior year.
• Non Operating Income was -$360000.0 for Q3 2025 at Dianthus Therapeutics, down from $3.3 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $4.7 million in Q3 2024 to a low of -$2.3 million in Q4 2023.
• Historically, Non Operating Income has averaged $1.6 million across 4 years, with a median of -$2000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Non Operating Income tumbled 5216.28% in 2023, then surged 136633.33% in 2024.
• A 4-year view of Non Operating Income shows it stood at -$43000.0 in 2022, then sank by 5216.28% to -$2.3 million in 2023, then jumped by 252.06% to $3.5 million in 2024, then tumbled by 110.36% to -$360000.0 in 2025.
• The last three Non Operating Income figures came in at -$360000.0 (Q3 2025), $3.3 million (Q2 2025), and $3.7 million (Q1 2025), per Business Quant data.